Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.

Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.

http://www.wikidata.org/entity/Q35098539

about

Applications of metabolomics in cancer research Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases Hepatocellular carcinoma: Review of disease and tumor biomarkers Metabonomic window into hepatitis B virus-related hepatic diseases Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospects Considerations regarding current diagnosis and prognosis of hepatocellular carcinoma Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review Bladder cancer biomarker discovery using global metabolomic profiling of urine Rats' urinary metabolomes reveal the potential roles of functional foods and exercise in obesity management.Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma Potential metabolic mechanism of girls' central precocious puberty: a network analysis on urine metabonomics data.Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes.A weighted relative difference accumulation algorithm for dynamic metabolomics data: long-term elevated bile acids are risk factors for hepatocellular carcinoma.biosigner: A New Method for the Discovery of Significant Molecular Signatures from Omics Data.Small heterodimer partner overexpression partially protects against liver tumor development in farnesoid X receptor knockout mice.Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis.The metabolomic window into hepatobiliary disease.Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients.Microscale depletion of high abundance proteins in human biofluids using IgY14 immunoaffinity resin: analysis of human plasma and cerebrospinal fluid.LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort.Low-mass-ion discriminant equation: a new concept for colorectal cancer screening High fat diet feeding exaggerates perfluorooctanoic acid-induced liver injury in mice via modulating multiple metabolic pathways.Metabonomics identifies serum metabolite markers of colorectal cancer.Detection of pancreatic cancer biomarkers using mass spectrometry Urinary metabolite profiling offers potential for differentiation of liver-kidney yin deficiency and dampness-heat internal smoldering syndromes in posthepatitis B cirrhosis patients.A metabolomics approach to stratify patients diagnosed with diabetes mellitus into excess or deficiency syndromes.Very low carbohydrate diet significantly alters the serum metabolic profiles in obese subjects.Plasma metabolite biomarkers for the detection of pancreatic cancer NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.EPMA position paper in cancer: current overview and future perspectives.Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research.GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort Metabolomics for Biomarker Discovery: Moving to the Clinic Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis Chromatographic determination of some biomarkers of liver cirrhosis and hepatocellular carcinoma in Egyptian patients.Metabolomics Identifies Biomarker Pattern for Early Diagnosis of Hepatocellular Carcinoma: from Diethylnitrosamine Treated Rats to Patients.

P2860

Q24600728-79D4C79B-D5ED-4339-A639-7B29C2ACBABF Q26741550-990AFA7B-C4B1-49AA-AE09-445AE3B154D4 Q26750796-08983FF8-BA1F-4896-88BC-ED07F64AB4EC Q26771253-B2CE27ED-3507-45E2-A744-D86B9B37C63A Q27021265-740ADAA9-1E3E-461B-93DA-7132B5609FC3 Q28082223-D05B4F0E-6364-4DB8-A371-56F81D059AB3 Q28083342-34B9FE4C-4EC7-4FF0-B240-832AF609EA0A Q28542873-44EA3C1A-407E-49A9-A76C-360F08566B21 Q30313428-41158E26-23CE-47E7-8CD9-04A34CC165A2 Q30414018-F86198D8-2A97-4BD8-ACD9-9C96F975FB33 Q30584137-BE77113A-9961-409B-955F-BBCBDF3D1980 Q30649847-F1FD90E5-BD93-497F-BC4D-C8BCCEC157A6 Q30908240-3431D9D0-F20D-4F10-B243-47F33CCBE9CD Q31116678-B02571BE-DB94-4AF5-9355-7ADEBF8DC34A Q33688789-DEB2245B-2A94-418F-BFB2-D53757CCAE12 Q33860653-FAA63F32-926C-4FFC-A0B7-BD257192A79A Q33893457-7EDD8DAB-DE8C-4160-8475-4166460AE7EC Q34038257-FBB90BE3-E137-42BA-9CF0-45BF51099780 Q34214476-3823F6BD-7A50-4B50-8A8A-0E804D32A759 Q34339067-D405C9EC-46C4-4949-A0CF-DA2CD6D0EC8A Q34401658-93835980-E988-4A8F-BBB4-7DB901265C6F Q34451211-8850AEF0-1FBE-4041-816E-1FCEC9B8B69D Q34521993-DED82ED3-E095-479E-926C-964381D1A332 Q34692127-EC6D58B6-633F-404B-A4EF-6EB02791DA56 Q34723672-0CAF4AEC-CD91-4FD2-A3C8-8C9B8A753575 Q34853258-D0B5D002-533A-4AA1-9D3A-85710A93265F Q35034053-61699C5E-DF49-417D-9169-FFBE7FA30F80 Q35034063-FC1F6827-9614-4119-96CB-1A436381325C Q35041720-556823C4-30BB-40D4-9345-4055B6CB1134 Q35072866-62F40521-24C2-4B1E-8072-BAE86D286B14 Q35079419-127887F6-54FA-411D-85A3-25648C11316D Q35532215-94042C08-6A96-4AAD-98CD-C9AEF44F7523 Q35571752-941BE722-D03D-4CBA-A0FF-B9CBA5E980D3 Q35648370-0ACF59E8-9437-4CF5-BEA5-737A5FC2CA34 Q35674401-B333A66F-8B05-49B5-8E97-E355EB0FCB0F Q36001686-80BDA0B9-088B-4D21-98E6-F4F3839E5354 Q36144160-0C3D7883-3E36-445E-9BAF-EAFF0B3EF7FC Q36165635-9CB3D0AB-C98B-46AE-9785-E273C90FC0B1 Q36197829-E2E56820-2422-4E3D-AA0B-E14DADA654CF Q36242221-B679E318-6D73-4F55-BDB1-F9A55F07C45A

P2860

Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.

http://www.wikidata.org/entity/Q35098539

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Serum and urine metabolite pro ...... uman hepatocellular carcinoma.

@ast

Serum and urine metabolite pro ...... uman hepatocellular carcinoma.

@en

type

label

Serum and urine metabolite pro ...... uman hepatocellular carcinoma.

@ast

Serum and urine metabolite pro ...... uman hepatocellular carcinoma.

@en

prefLabel

Serum and urine metabolite pro ...... uman hepatocellular carcinoma.

@ast

Serum and urine metabolite pro ...... uman hepatocellular carcinoma.

@en

P1433

Q35098539-72AB6E72-DC6F-423A-90A2-18CAE2AAF343

P1476

Q35098539-11330CC1-7409-48D1-8BE4-4F24FF007FA9

P2093

Q35098539-0A0F3DE8-F844-49B0-92CC-8D247C5EFB81

Q35098539-19965495-8DEB-4D22-99ED-8C68F533D469

Q35098539-3699A189-22FC-48B2-B66F-79AC65F8F8B9

Q35098539-52B4FD5F-17C0-4EC9-8DC6-9945A311379A

Q35098539-6ECDE61E-99B8-4CF0-8FE6-FE3FE34DF829

Q35098539-91F7D0CA-126B-45B7-8C69-B49807F70C5E

Q35098539-9723438E-D0C6-4915-8995-2D6E669E4C2C

Q35098539-9F30E231-CF60-454E-BD03-1BD2113B37D9

Q35098539-A113EE58-0AA4-4EEE-9B39-3A9ADD6C3E41

Q35098539-C06224F7-AE18-42F8-9213-B6B31C51E4CB

P2860

Q35098539-054EE1E5-C0C7-40FB-9D00-83704D8E1F3C

Q35098539-0B229FE2-DD51-4FD7-B524-CF57D065A8FB

Q35098539-11B56FC0-B3E0-457F-AC24-F6376E72B8EB

Q35098539-1217BB92-25FE-4894-8A31-F120C4814B3B

Q35098539-12C70A75-4725-4A24-B2EB-84D4D143FF81

Q35098539-1518D441-4E93-4D7F-BE48-FBA366BD9CAC

Q35098539-194CFC89-E078-43D0-88DD-D3FE1598AE58

Q35098539-1C66E733-2975-4526-A825-8F1322F379EA

Q35098539-1F95E021-DB9C-4498-B6FF-F7EEEE6302AF

Q35098539-466C0793-F4E1-44F5-A229-14ACD3DFAAF6

P304

Q35098539-1A7D3147-1D24-40E2-9E66-666BA2FB70A6

P31

Q35098539-4C4456C6-7D59-44FB-8B99-0AD13D9D0D13

P356

Q35098539-57F57007-8F7C-40F9-8A4B-9F48DE3D8692

P433

Q35098539-7B629D38-B378-41F1-95A7-33287D79783B

P478

Q35098539-947028AF-8C0E-45EC-9218-5A949FD4ED40

P577

Q35098539-728D3489-10BA-411E-AC5A-5848ACDBF01E

P698

Q35098539-53473EDB-CB68-42A0-9BDB-A6176BCAE4CC

P921

Q35098539-FEA07387-02BA-40AB-BFD6-FE9951323AB7

P932

Q35098539-8527E220-8401-4EF6-9377-22F7D118445F

P356

MCP.M110.004945

P1433

Molecular & Cellular Proteomics

P1476

Serum and urine metabolite pro ...... uman hepatocellular carcinoma.

@en

P2093

Guoxiang Xie

http://www.w3.org/2001/XMLSchema#string

Jia Fan

http://www.w3.org/2001/XMLSchema#string

Lisa X Xu

http://www.w3.org/2001/XMLSchema#string

Mingming Su

http://www.w3.org/2001/XMLSchema#string

Ping Liu

http://www.w3.org/2001/XMLSchema#string

Tianlu Chen

http://www.w3.org/2001/XMLSchema#string

Wei Jia

http://www.w3.org/2001/XMLSchema#string

Xiaojiao Zheng

http://www.w3.org/2001/XMLSchema#string

Xiaoyan Wang

http://www.w3.org/2001/XMLSchema#string

Xiaoying Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data

High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses.

Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models.

Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review.

Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis.

Metabolomics reveals metabolic biomarkers of Crohn's disease

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.

P304

M110.004945

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/MCP.M110.004945

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21518826

http://www.w3.org/2001/XMLSchema#string

P921

P932

3134066

http://www.w3.org/2001/XMLSchema#string